A previous study reported that knockdown of AKR1B10 can significantly inhibit p53-induced apoptosis of CRC cells, while overexpression of AKR1B10 enhances p53-induced apoptosis and inhibits tumor proliferation in vivo [22]. Here, AKR1B10 is linked to neoplasm.